Details

Autor(en) / Beteiligte

• Okamoto, Hiroyuki
• Iijima, Kotaro
• Chiba, Takahito
• Takemori, Mihiro
• Nakayama, Hiroki
• Fujii, Kyohei
• Kon, Mitsuhiro
• Mikasa, Shohei
• Nakaichi, Tetsu
• Urago, Yuka
• Aikawa, Ako
• Katsuta, Shyouichi
• Nakamura, Satoshi
• Igaki, Hiroshi

Titel

Technical note: Analysis of brachytherapy source movement by high‐speed camera

Ist Teil von

• Medical physics (Lancaster), 2022-07, Vol.49 (7), p.4804-4811

Ort / Verlag

United States

Erscheinungsjahr

2022

Quelle

Wiley-Blackwell Journals

Beschreibungen/Notizen

• Purpose To assess the accuracy of the movement of a brachytherapy source using a high‐speed camera for evaluating source position, dwell time, and transit dose. Methods A high‐speed camera was used to record the source position of an Ir‐192 source relative to a ruler within a custom positioning jig in a remote afterloading system. The analyzed frames can be used to assess dwell positions and times. Treatment plans had multiple dwell times equal to 0.1, 0.5, 1.0, and 2.0 s in 2.5‐ and 5‐mm step sizes. Images were acquired at a rate of 146 frames/s. Acquired images were processed to automatically track the actual source using the correlation between a template image and each frame. The brachytherapy dose calculation formalism (AAPM TG43‐U1) was applied to each frame to evaluate the transit dose contribution to the total dose. Results The differences in measured source positions from the nominal for dwell times equal to 0.1, 0.5, 1.0, and 2.0 s in treatment plans were approximately ≤1 mm. The corresponding differences in measured dwell times from the nominal values at 5 mm steps were −15, −9, −5, and 5 ms, respectively. The source velocities at 5 mm steps were approximately 393 mm/s. The dose differences at 5 mm from the source movement with and without the transit dose for these dwell times were 38%, 7%, 3%, and 2%, respectively. Conclusions Recording a brachytherapy source using a high‐speed camera allowed the evaluation of positional and dwell time accuracies as well as dosimetry assessments, such as the transit dose, based on the application of AAPM TG‐43U1.